Switch to:

Regulus Therapeutics Inc (RGLS) Ownership Data

Short Interest History (%)

This is the historical short interest of Regulus Therapeutics Inc, as measured by the Short Percentage Of Float.

Date Short Interest
August 14, 201535.1
July 31, 201535.79
July 15, 201535.86
June 30, 201532.12
June 15, 201528.81
May 29, 201528.24
May 15, 201527.98
April 30, 201524.94
April 15, 201526.78
March 31, 201527.54
March 13, 201525.33
February 27, 201526.06
February 13, 201513.23
January 30, 201554.27
January 15, 201550.65
December 31, 201450.93
December 15, 201440.61
November 28, 201438.13
November 14, 201441.33
October 31, 201438.55
October 15, 201410.92
September 30, 201411.02
September 15, 201410.08
August 29, 20149.75
August 15, 20149.65
July 31, 20149.74
July 15, 20149.46
June 30, 20149.1
June 13, 20149.24
May 30, 20149.57
May 15, 20149.77
April 30, 20149.18
April 15, 20149.88
March 31, 201411.8
March 14, 201411.96
February 28, 201415
February 14, 201417.25
January 31, 201414.99
January 15, 201410.05
December 31, 20138.57
December 13, 20137.07
November 29, 20137.57
November 15, 20139.49
October 31, 201311.76
October 15, 201314.25
September 30, 201313.21
September 13, 201313.42
August 30, 201312.58
August 15, 201311.7
July 31, 20136.87
July 15, 20133.32
June 28, 20134.4
June 14, 20133.54
May 31, 20133.28
May 15, 20133.4
April 30, 20133.7
April 15, 20132.92
March 28, 20132.42
March 15, 20132.38
February 28, 20132.37
February 15, 20132.6
January 31, 20132.41
January 15, 20132.42
December 31, 20122.83
December 14, 20120.02
November 30, 20120.01
November 15, 20120.01
October 31, 20120.02
October 15, 20120.01

Institutional Ownership History (%)

This the Institutional Ownership History of Regulus Therapeutics IncPeter Lynch prefers to buy companies with low institutional ownership.

Date Institutional Ownership
June 30, 201566
March 31, 201565
December 31, 201494
September 30, 201434
June 30, 201434
March 31, 201494
December 31, 201340
September 30, 201334
June 30, 201323
March 31, 201396
December 31, 201240

Insider ownership (%)

This is the historical insider ownership of Regulus Therapeutics Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Dr. Stelios Papadopoulos,PhDN/A200,6770.39%2015-08-07
Mark G. FolettaDirector10,000less than 0.1%2015-08-13
Dr. Kleanthis G. Xanthopoulos,PhDPresident and CEO3,705less than 0.1%2015-04-17

Top Fund Holders

HolderSharesReport Date% of Shares
Outstanding
% of Total
Assets Managed
Market Value($1000)
Fidelity Management and Research Company   Premium Plus7,652,6102015-06-3015.000.0183,873
Alnylam Pharmaceuticals Inc5,896,7162014-12-3112.05N/A94,583
Wellington Management Company LLP   Premium Plus4,853,4422015-06-309.510.0153,194
AstraZeneca PLC4,250,0002014-12-318.68N/A68,170
RA Capital Management, LLC   Premium Plus3,790,4762015-06-307.434.1841,544
Fidelity® Growth Company Fund3,404,2472015-06-306.670.0937,311
Isis Pharmaceuticals Inc.2,843,1722015-07-225.57N/A31,161
State Street Corp   Premium Plus2,659,2852015-06-305.21N/A29,145
SPDR® S&P Biotech ETF2,423,3472015-08-194.300.7218,005
Capital World Investors   Premium Plus2,015,0002015-06-303.950.0122,084

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK